Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas
- 24 October 2016
- journal article
- letter
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 51 (12) , 1617-1619
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The role of high dose chemotherapy and autologous stem-cell transplantation in peripheral T-cell lymphoma: A review of the literature and new perspectivesCancer Treatment Reviews, 2013
- High-Throughput Sequencing Detects Minimal Residual Disease in Acute T Lymphoblastic LeukemiaScience Translational Medicine, 2012
- Flow Cytometric Immunophenotypic Assessment of T-Cell Clonality by Vβ Repertoire AnalysisAmerican Journal of Clinical Pathology, 2011
- In‐vivo purging of the circulating clonal T‐cells with Alemtuzumab prior to autologous peripheral blood hematopoietic cell mobilization and transplantationBritish Journal of Haematology, 2011
- Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classificationAnnals of Oncology, 2004
- Bone marrow histopathology in peripheral T‐cell lymphomasBritish Journal of Haematology, 2004
- Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT)Bone Marrow Transplantation, 2003
- Immunophenotypic Analysis of Peripheral T-Cell NeoplasmsAmerican Journal of Clinical Pathology, 2001
- Molecular and flow cytometric analysis of the Vβ repertoire for clonality assessment in mature TCRαβ T-cell proliferationsBlood, 2001
- The Risk of Tumor Cell Contamination in Peripheral Blood Stem Cell CollectionsJournal of Hematotherapy, 1992